| Farnaz Farhi, MD | |
|
2150 Pennsylvania Ave Nw Fl 5, Washington, DC 20037-3201 | |
| (202) 741-2500 | |
| (202) 741-2550 |
| Full Name | Farnaz Farhi |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 2150 Pennsylvania Ave Nw Fl 5, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578910089 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD048565 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| George Washington University Medical Faculty Associates | 4082528898 | 651 |
News Archive
TSU neuroscientists and their colleagues from SibSMU plan to introduce a new approach to studying brain damage in patients with Parkinson's disease
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
Scientists at Wake Forest Institute for Regenerative Medicine have developed the most sophisticated mini-livers to date.
Scientists at NYU Langone Medical Center's Center for Cognitive Neurology have evidence that monoclonal antibodies they developed may provide the blueprint for effective treatments for Alzheimer's disease and other neurodegenerative diseases, such as Parkinson's disease.
Insmed Incorporated, a biopharmaceutical company, today reported results for the second quarter and six-months ended June 30, 2011.
› Verified 6 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
TSU neuroscientists and their colleagues from SibSMU plan to introduce a new approach to studying brain damage in patients with Parkinson's disease
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
Scientists at Wake Forest Institute for Regenerative Medicine have developed the most sophisticated mini-livers to date.
Scientists at NYU Langone Medical Center's Center for Cognitive Neurology have evidence that monoclonal antibodies they developed may provide the blueprint for effective treatments for Alzheimer's disease and other neurodegenerative diseases, such as Parkinson's disease.
Insmed Incorporated, a biopharmaceutical company, today reported results for the second quarter and six-months ended June 30, 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Farnaz Farhi, MD 2150 Pennsylvania Ave Nw Fl 5, Washington, DC 20037-3201 Ph: (202) 741-2500 | Farnaz Farhi, MD 2150 Pennsylvania Ave Nw Fl 5, Washington, DC 20037-3201 Ph: (202) 741-2500 |
News Archive
TSU neuroscientists and their colleagues from SibSMU plan to introduce a new approach to studying brain damage in patients with Parkinson's disease
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
Scientists at Wake Forest Institute for Regenerative Medicine have developed the most sophisticated mini-livers to date.
Scientists at NYU Langone Medical Center's Center for Cognitive Neurology have evidence that monoclonal antibodies they developed may provide the blueprint for effective treatments for Alzheimer's disease and other neurodegenerative diseases, such as Parkinson's disease.
Insmed Incorporated, a biopharmaceutical company, today reported results for the second quarter and six-months ended June 30, 2011.
› Verified 6 days ago
Dr. Steven Joseph Ralston, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2150 Pennsylvania Ave Nw, Washington, DC 20037 Phone: 202-741-2500 | |
Gloria Bowles-johnson, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8232 | |
Mary Melody Abraham, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1145 19th St Nw, Suite 410, Washington, DC 20036 Phone: 202-331-1740 Fax: 202-296-9784 | |
Dr. Edward James Tanner Iii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5275 Loughboro Rd Nw Bldg D, Washington, DC 20016 Phone: 202-243-5295 Fax: 202-537-4662 | |
Dr. Richard J. Beckerman, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 5215 Loughboro Rd Nw, Suite 500, Washington, DC 20016 Phone: 202-243-3500 Fax: 202-966-8441 | |
Kimberly Suzanne Moon, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2021 K St Nw, Suite 701, Washington, DC 20006 Phone: 202-296-2595 Fax: 202-296-2835 | |
Dr. Deborah Martina Smith, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1701 14th St Nw, Elizabeth Taylor Medical Center, Washington, DC 20009 Phone: 202-745-7000 Fax: 202-745-0238 |